Risk factors for adverse outcomes after peritonitis-related technique failure

Peritoneal Dialysis International

Volumn 28, Issue 4, 2008, Pages 352-360

  Moon, Sung Jin ^a   Han, Seung Hyeok ^a   Kim, Dong Ki ^a   Lee, Jung Eun ^a   Kim, Beom Seok ^a   Kang, Shin Wook ^a   Choi, Kyu Hun ^a   Lee, Ho Yung ^a   Han, Dae Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

C reactive protein; Complications; Peritonitis

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEPHALOSPORIN; VANCOMYCIN;

ADULT; ARTICLE; ASCITES; CANDIDA; CATHETER REMOVAL; CAUSE OF DEATH; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ESCHERICHIA COLI; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PSEUDOMONAS; RETROSPECTIVE STUDY; SCLEROSING PERITONITIS; TREATMENT DURATION;

EID: 48749111081     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800409     Document Type: Article

References (29)

1. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20:2587-93.
2. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, et al. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis 2007; 49:A6-7, S1-296.
3. Gokal R, Jakubowski C, King J, Hunt L, Bogle S, Baillod R, et al. Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study. Lancet 1987; 2:1105-9.
4. Maiorca R, Cancarini GC, Zubani R, Camerini C, Manili L, Brunori G, et al. CAPD viability: a long-term comparison with hemodialysis. Perit Dial Int 1996; 16:276-87.
5. Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983; 2:642-4.
6. Shetty A, Oreopoulos DG. Connecting devices in CAPD and their impact on peritonitis. J Postgrad Med 1994; 40: 179-84.
7. Chin AI, Yeun JY. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am J Kidney Dis 2006; 47:697-712.
8. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20:828-9]. Perit Dial Int 2000; 20:396-411.
9. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107-31.
10. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S43-55.
11. Kawanishi H. Encapsulating peritoneal sclerosis. Nephrology (Carlton) 2005; 10:249-55.
12. Han SH, Lee SC, Ahn SV, Lee JE, Kim DK, Lee TH, et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 2007; 22:2653-8.
13. Chow KM, Szeto CC, Leung CB, Kwan BC, Law MC, Li PK. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int 2005; 25:374-9.
14. Choi P, Nemati E, Banerjee A, Preston E, Levy J, Brown E. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization. Am J Kidney Dis 2004; 43:103-11.
15. Noh H, Lee SW, Kang SW, Shin SK, Choi KH, Lee HY, et al. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patient. Perit Dial Int 1998; 18:387-94.
16. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM. C-reactive protein and cardiovascular disease in peritoneal dialysis patient. Kidney Int 2002; 62: 1417-22.
17. Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patient? J Am Soc Nephrol 2003; 14:1871-9.
18. Zalunardo NY, Rose CL, Ma IW, Altmann P. Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis. Kidney Int 2007; 71:687-92.
19. Hind CR, Thomson SP, Winearls CG, Pepys MB. Serum C-reactive protein concentration in the management of infection in patient treated by continuous ambulatory peritoneal dialysis. J Clin Pathol 1985; 38:459-63.
20. Park MS. Factors increasing severity of peritonitis in Long-term peritoneal dialysis patients. Adv Ren Replace Ther 1998; 5:185-93.
21. Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) group. Perit Dial Int 2000; 20(Suppl 2):S106-13.
22. Mortier S, Lameire NH, De Vriese AS. The effects of peritoneal dialysis solutions on peritoneal host defense. Perit Dial Int 2004; 24:123-38.
23. Mortier S, De Vriese AS, McLoughlin RM, Topley N, Schaub TP, Passlick-Deetjen J, et al. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol 2003; 14:1296-306.
24. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl4):S19-29.
25. Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002; 22:573-81.
26. Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F. Peritonitis-related mortality in patient undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25:274-84.
27. Devuyst O, Nielsen S, Cosyns JP, Smith BL, Agre P, Squifflet JP, et al. Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol 1998; 275:H234-42.
28. Cejudo-Martin P, Ros J, Navasa M, Fernandez J, Fernandez-Varo G, Ruiz-del-Arbol L, et al. Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patient with spontaneous bacterial peritonitis. Hepatology 2001; 34:487-93.
29. Tzamaloukas AH, Murata GH, Fox L. Peritoneal catheter loss and death in continuous ambulatory peritoneal dialysis peritonitis: correlation with clinical and biochemical parameters. Perit Dial Int 1993; 13(Suppl 2): S338-40.